Can We Stop Multiple Sclerosis and ALS? - New Approaches to Nerve Cell Regeneration
Groundbreaking research on nerve cell death in MS and ALS leads to potential new treatments. Dr. Levin discusses discoveries in stopping cell death and promoting regeneration, offering hope for halting disease progression.
Gamechangers in Medicine - May 1, 2024
Explore groundbreaking advancements and innovations in the medical field with insights from a leading pharmacology expert, focusing on recent developments that are reshaping healthcare practices.
Using Dogs and Cats for Human Pain Research
Exploring innovative approaches to pain research using pet and farm animals with naturally occurring diseases to develop safer, more effective painkillers for both humans and animals.
A Drug Developed for Women by Women - Advancing Sex-Specific Treatments
Exploración de diferencias de género en trastornos psiquiátricos y desarrollo de tratamientos específicos para mujeres, destacando la importancia de la investigación centrada en el sexo femenino.
Taking on Autoimmune Diseases with Worms
Explore the intriguing connection between parasitic worms and autoimmune diseases, and learn about potential worm-derived treatments that could revolutionize autoimmune disorder management.
Bayer's ALYCE - Advancing Drug Development with Data Intelligence
Discover how Bayer's ALYCE platform revolutionizes clinical trials using data intelligence, AI, and machine learning to enhance patient-centric study designs and expedite drug development while ensuring regulatory compliance.
Target Deconvolution Explanation - Lab 4
Explore target deconvolution techniques in drug discovery through hands-on lab exercises led by experts Ali Denton and Kristina Ulicna.
Autoimmune Diseases - The Arising Opportunities for Cell Therapies
Explore the potential of CAR-T cell therapies in treating autoimmune diseases, focusing on recent advancements and future opportunities for potentially curative approaches beyond oncology.
The Experience of Development and Verification of Analytical Platforms for Cellular and Gene Therapy
Explore development and verification processes for analytical platforms in cellular and gene therapy, focusing on key challenges and innovative solutions.
Platform Trials: Accelerating Clinical Research in Scleroderma - 2024 Patient Forum
Explore platform trials and their impact on scleroderma research, focusing on CONQUEST, an innovative trial designed to rapidly advance promising treatments and identify agents for phase 3 trials.
Essentials of Clinical Trials - A Patient's Guide
Discover the essentials of clinical trials, including participation benefits, expectations, and processes, with expert guidance from Dr. Peter Merkel.
Scleroderma Research: Past, Present and Future
Explore scleroderma clinical trials: past successes, FDA approval process, trial design, oversight, eligibility criteria, and considerations for participation.
Scleroderma Research Progress: 25 Years of Advancements and Future Prospects - 2023 Closing Keynote
Explore 25 years of scleroderma research progress and future prospects towards finding a cure with Dr. Feghali-Bostwick's insightful keynote address.
Scleroderma Clinical Treatment Trials - Are They Right for You?
Explore Scleroderma clinical trials with Dr. Mayes: learn about finding trials, evaluating suitability, and making informed decisions for your treatment journey.
Concept-to-Commercialization: Thermo Fisher's Unique Approach to Rapidly Advancing Antibody and Protein Therapeutics
Discover Thermo Fisher's innovative approach to accelerate antibody and protein therapeutics development, from gene optimization to first-in-human trials, through an integrated workflow.
Cell Validation and Drug-Induced Liver Injury Using a Human Liver Microphysiological System
Explore predictive human liver models for drug development using microphysiological systems. Learn about cell validation and drug-induced liver injury assessment to improve preclinical testing accuracy.
Making Your Research Translatable: The Example of RENACER
Explore translational research strategies through RENACER example, enhancing impact of scientific discoveries in clinical settings.
Proliferation Biomarkers in Drug Discovery and Development - The Immunoassay of Thymidine Kinase 1
Explore the role of proliferation biomarkers in drug discovery, focusing on Thymidine Kinase 1 immunoassay for monitoring cell proliferation in tumors and its potential in therapeutic response assessment.
Current Landscape and Future Directions of Multi-specific Antibodies
Explore advancements in multi-specific antibodies, their applications in disease treatment, and challenges in development. Gain insights into preclinical research and future directions of this promising therapy.
The Future of Antibody Drug Discovery - From Target Validation to Candidate Selection
Explore the antibody drug discovery process, from target validation to candidate selection, highlighting key steps, advancements, and challenges in developing effective therapeutics.
CNS Delivery in Drug Development and Toxicology - Best Practices and Recent Advances
Explore best practices and recent advances in CNS drug delivery for development and toxicology, focusing on emerging therapies, translational challenges, and innovative dosing approaches.